Literature DB >> 9610170

Lysis of human red blood cells. 3: Effect of contact time on surfactant-induced hemolysis.

J F Krzyzaniak1, S H Yalkowsky.   

Abstract

The percent hemolysis induced by various surfactants was determined as a function of the formulation composition and formulation: blood contact time using the dynamic in vitro method of Krzyzaniak et al. (1). The amount of hemolysis induced by nonionic surfactant formulations is shown to be relatively low and to increase only slightly with contact time. However, when ionic surfactant formulations are used, hemolysis is shown to increase dramatically with surfactant concentration and to be sigmoidally related to the logarithm of contact time. Since surfactant-induced hemolysis is dependent on both the surfactant concentration and the contact time, intravascular hemolysis must be evaluated using an in vitro method that simulates the intravenous injection site. With this information, hemolytically safe surfactant formulations can be developed for intravenous administration.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610170

Source DB:  PubMed          Journal:  PDA J Pharm Sci Technol        ISSN: 1079-7440


  7 in total

1.  Composition optimization and stability testing of a parenteral antifungal solution based on a ternary solvent system.

Authors:  Kristóf Kovács; István Antal; György Stampf; Imre Klebovich; Krisztina Ludányi
Journal:  AAPS PharmSciTech       Date:  2010-02-24       Impact factor: 3.246

2.  Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.

Authors:  Heena V Maithania; Bhabani S Mohanty; Pradip R Chaudhari; Abdul Samad; Padma V Devarajan
Journal:  Drug Deliv Transl Res       Date:  2020-02       Impact factor: 4.617

3.  Method for analysis of nanoparticle hemolytic properties in vitro.

Authors:  Marina A Dobrovolskaia; Jeffrey D Clogston; Barry W Neun; Jennifer B Hall; Anil K Patri; Scott E McNeil
Journal:  Nano Lett       Date:  2008-07-08       Impact factor: 11.189

4.  Buparvaquone loaded solid lipid nanoparticles for targeted delivery in theleriosis.

Authors:  Maheshkumar P Soni; Nilakash Shelkar; Rajiv V Gaikwad; Geeta R Vanage; Abdul Samad; Padma V Devarajan
Journal:  J Pharm Bioallied Sci       Date:  2014-01

5.  Biomimetic Targeted Theranostic Nanoparticles for Breast Cancer Treatment.

Authors:  Suphalak Khamruang Marshall; Pavimol Angsantikul; Zhiqing Pang; Norased Nasongkla; Rusnah Syahila Duali Hussen; Soracha D Thamphiwatana
Journal:  Molecules       Date:  2022-10-01       Impact factor: 4.927

6.  Anti-EGFR Targeted Multifunctional I-131 Radio-Nanotherapeutic for Treating Osteosarcoma: In Vitro 3D Tumor Spheroid Model.

Authors:  Suphalak Khamruang Marshall; Boonyisa Saelim; Maneerat Taweesap; Verachai Pachana; Yada Panrak; Naritsara Makchuchit; Passara Jaroenpakdee
Journal:  Nanomaterials (Basel)       Date:  2022-10-08       Impact factor: 5.719

7.  Assessment of interactions of efavirenz solid drug nanoparticles with human immunological and haematological systems.

Authors:  Neill J Liptrott; Marco Giardiello; Tom O McDonald; Steve P Rannard; Andrew Owen
Journal:  J Nanobiotechnology       Date:  2018-03-15       Impact factor: 10.435

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.